Acrivon Therapeutics ACRV
- ACR-525 — Eosinophilic Esophagitis
- ACR-525 — Inflammatory Bowel Disease
JAK1 (3 companies · 4 programs)
Companies with an active program directed at JAK1.
Aclaris Therapeutics ACRS
- lepzacitinib — Atopic Dermatitis Phase 2
EyePoint, Inc. EYPT
- DURAVYU — Diabetic Macular Edema Phase 3